- Research Tracker
- Non-drug evidence map
- Omega-3 fatty acids and fish oil
Omega-3 fatty acids from fish, krill or algae oil. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.
Trials by condition
Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.
What these trials measure
Primary outcomes, grouped by keyword rules: Symptom severity and disease activity (45), Inflammation and other biomarkers (44), Weight and metabolic markers (31), Mood, anxiety and wellbeing (20), Heart rate, blood pressure and autonomic (15), Clinical events, survival and healthcare use (13), Cognition (13), Feasibility, adherence and safety (9), Physical function and exercise capacity (8), Pain (7), Breathing and lung function (5), Quality of life (3).
Names used for this class in the registry
omega-3 fatty acid, fish oil, omega-3 fatty acids, omega-3, omega 3 fatty acids, omega-3 supplementation, omega-3 polyunsaturated fatty acids, docosahexaenoic acid (dha), krill oil, omega-3-acid ethyl esters, omega 3, omega 3 fatty acid
Download all 188 trials (CSV) All non-drug classes
Related in Supplements and nutraceuticals: Vitamin D · Probiotics, prebiotics and synbiotics · Coenzyme Q10 · NAD+ precursors (nicotinamide riboside, NMN) · N-acetylcysteine · Magnesium · Zinc · Melatonin · Creatine · Vitamin C · B vitamins and folate · Curcumin and other polyphenols · Amino acids and protein supplements · Herbal medicines and traditional formulas · Other vitamins, minerals and multivitamins · Other supplements and nutraceuticals
Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.